TITLE

New Clinical Advisory Issued by National Institute of Neurological Disorders and Stroke (NINDS)

PUB. DATE
September 2011
SOURCE
NLM Technical Bulletin;Sep2011, Issue 382, p11
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on the new clinical advisory by the National Institute of Neurological Disorders and Stroke (NINDS). It states that NINDS stopped the combination antiplatelet therapy for Secondary Prevention of Small Subcortical Strokes (SPS3) with randomized clinical trial in North America, Latin America and Spain. It mentions that the clinical trial aims to prevent second stroke in patients who suffered from subcortical stroke.
ACCESSION #
70328351

 

Related Articles

  • Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence. DAVIS, KYLE A.; MIYARES, MARTA A.; DIETRICH, ERIC // American Journal of Health-System Pharmacy;10/1/2015, Vol. 72 Issue 19, p1623 

    Purpose. The safety and efficacy of dual antiplatelet therapy (DAPT) with aspirin and clopidogrel in the setting of secondary stroke prevention are reviewed. Summary. Antiplatelet therapy has been shown to reduce the risk of numerous vascular events, especially in the setting of secondary...

  • Reducing Stroke Risk After TIA or Minor Ischemic Stroke.  // Clinical Oncology Alert;Sep2013 Clincal Briefs, p17 

    The article discusses the study of Y. Wang and colleagues regarding the efficacy of low-dose aspirin and clopidogrel in reducing the risk of stroke after minor ischemic stroke or transient ischemic attack (TIA) in Chinese subjects.

  • Triple Antiplatelet Therapy in Obese Patients Undergoing Stent Implantation. Balta, Sevket; Demirkol, Sait; Celik, Turgay; Unlu, Murat; Arslan, Zekeriya; Haqmal, Hamidullah // Angiology;Oct2013, Vol. 64 Issue 7, p559 

    A letter to the editor is presented in response to the article "Angiology efficacy and safety of triple antiplatelet" by W. Gao and colleagues in the January 27, 2013 issue.

  • Prescribing antiplatelets. Morris, David // Independent Nurse;1/15/2010, p1 

    The article focuses on the prescription of oral antiplatelet agents, aspirin, clopidogrel, and prasugrel, for treating cardiovascular disease (CVD). It recommends the use of low dose aspirin along with a proton pump inhibitor (PPI) and states that even though clopidogrel is little more effective...

  • Reducing Stroke Risk After TIA or Minor Ischemic Stroke. Kuritzky, Louis // Clinical Cardiology Alert;Sep2013 Clinical Briefs, p17 

    The article discusses the clinical trials conducted regarding the efficacy of dual antiplatelet therapy in reducing risk of stroke in patients who suffered transient ischemic attack (TIA) or minor ischemic stroke.

  • Reducing Stroke Risk After TIA or Minor Ischemic Stroke.  // Hospital Medicine Alert;Sep2013 Clinical Briefs in Primary Care, p17 

    The article discusses research on the effectiveness of clopidogrel and aspirin in reducing risk for stroke, with reference to a study by Y. Wang et al., published in "The New England Journal of Medicine" in 2013.

  • Clopidogrel could reduce stroke risk.  // Internal Medicine Alert;7/29/2013 Pharmacology Watch, p1 

    The article focuses on study conducted by China which found that use of combination of clopidogrel to aspirin in patients with minor stoke or a transient ischaemic attack reduces the risk of stroke in the next 90 days in comparison of patients who are treated with aspirin alone.

  • Clopidogrel plus aspirin may reduce stroke.  // Clinical Advisor;Aug2013, Vol. 16 Issue 8, p36 

    The article reports on a study conducted to patients with minor stroke or a transient ischemic attack (TIA) which reveals that a combined clopidogrel and aspirin therapy is more likely to reduce the risk of TIA than taking aspirin alone.

  • Secondary Prevention of Lacunar Stroke.  // Clinical Cardiology Alert;Nov2012 Clinical Briefs In Primary Care, p21 

    The article discusses the Secondary Prevention of Small Subcortical Strokes (SPS3) trial, which showed that Aspirin (ASA)+ clopidogrel (CLOP)was not as effective as ASA monotherapy in preventing lacunar strokes (L-CVA).

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics